Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients

Summary

This study is Randomized, Double-Blind, Vehicle-Controlled, Multiple-Dose Study. The purpose is to determine the safety, tolerability, systemic exposure and pharmacokinetics of ME1111 after repeated daily topical application of ME1111 in a maximal use setting in adults with distal subungual onychomycosis of the toenails.

Timeline

Start

2013-03

Primary completion

2013-08

Completion

—

Drugs

Indications